From the *Department of Anesthesiology and Critical Care Medicine, †Department of Surgery, and ‡Department of Hematology, The Johns Hopkins Medical Institutions, Baltimore, MD; and §Department of Surgery, University of California San Francisco School of Medicine, San Francisco, CA.
Reg Anesth Pain Med. 2017 Mar/Apr;42(2):197-203. doi: 10.1097/AAP.0000000000000542.
Venous thromboembolism (VTE) is a common cause of preventable harm. Perioperative thoracic epidural analgesia (TEA) presents a challenge to optimal VTE prophylaxis. Our primary aim was to characterize missed doses of VTE prophylaxis associated with epidural catheter placement and removal. Our secondary aim was to measure the effect of an enhanced recovery after surgery (ERAS) pathway on the rate of TEA-associated missed VTE prophylaxis.
We retrospectively reviewed a prospectively collected database of 1264 colorectal surgery patients at a single academic center. Missed preoperative doses between TEA patients and non-TEA patients were compared. Missed postoperative unfractionated heparin (UFH) doses associated with epidural removal were compared before and after implementation of an ERAS program. Other data collected included demographic data, surgical indication, and thrombohemorrhagic complications.
Of the 445 TEA patients, 12.6% missed their preoperative heparin doses compared with 8.4% of patients without epidurals (P = 0.017). Of the TEA patients prescribed 3 times daily UFH, 22.5% missed one or more doses associated with epidural removal. The percent of patients missing at least one dose of UFH on epidural removal dropped from 28.1% before ERAS to 17.9% after the ERAS program (P = 0.023). Seven patients developed VTEs. There were zero epidural hematomas.
Thoracic epidural analgesia was associated with a 1.5-fold increased risk of missed dose of preoperative VTE prophylaxis, which was not affected by implementation of an ERAS program. The implementation of an ERAS program reduced missed doses associated with epidural removal. This study highlights the challenge posed by providing VTE prophylaxis in the setting of perioperative neuraxial analgesia.
静脉血栓栓塞症(VTE)是一种常见的可预防伤害的原因。围手术期胸硬膜外镇痛(TEA)对最佳 VTE 预防提出了挑战。我们的主要目的是描述与硬膜外导管放置和移除相关的 VTE 预防措施的遗漏剂量。我们的次要目的是测量增强术后康复(ERAS)方案对 TEA 相关 VTE 预防措施遗漏率的影响。
我们回顾性分析了一家学术中心的 1264 例结肠直肠手术患者的前瞻性数据库。比较 TEA 患者和非 TEA 患者之间的术前遗漏剂量。比较 ERAS 方案实施前后与硬膜外移除相关的术后未分馏肝素(UFH)遗漏剂量。收集的其他数据包括人口统计学数据、手术指征和血栓栓塞并发症。
在 445 例 TEA 患者中,12.6%的患者漏用了术前肝素剂量,而无硬膜外的患者为 8.4%(P = 0.017)。在每天三次给予 UFH 的 TEA 患者中,有 22.5%的患者在硬膜外移除时漏用了一剂或多剂 UFH。在 ERAS 方案实施之前,至少有一剂 UFH 在硬膜外移除时漏用的患者比例为 28.1%,而在 ERAS 方案实施后降至 17.9%(P = 0.023)。有 7 例患者发生 VTE。无硬膜外血肿。
胸硬膜外镇痛与术前 VTE 预防措施遗漏剂量增加 1.5 倍相关,而实施 ERAS 方案并不影响这一结果。ERAS 方案的实施减少了与硬膜外移除相关的遗漏剂量。本研究强调了在围手术期神经轴镇痛背景下提供 VTE 预防措施所面临的挑战。